Royal Brompton & Harefield NHS Foundation Trust
rbht.nhs.ukLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
139
Active
19
Phase 3
9
Total enrollment
50,741
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Blood test for CFTR Genotyping | — | — | — | — | — | 1 | |
| Standard prednisolone taper | — | — | — | — | — | 1 | |
| Fast prednisolone taper | — | — | — | — | — | 1 |
Next readouts
- 2027-06-28
- 2028-06-01
Top conditions
- Cystic Fibrosis13
- Heart Failure12
- Idiopathic Pulmonary Fibrosis10
- Chronic Obstructive Pulmonary Disease6
- Lung Diseases5
- Persistent Atrial Fibrillation5
- Coronary Artery Disease5
- Interstitial Lung Disease4
Frequently asked questions about Royal Brompton & Harefield NHS Foundation Trust
- How many clinical trials does Royal Brompton & Harefield NHS Foundation Trust have on ClinicalTrials.gov?
- Royal Brompton & Harefield NHS Foundation Trust is listed as the lead sponsor on 139 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Royal Brompton & Harefield NHS Foundation Trust's trials are in Phase 3?
- 9 of Royal Brompton & Harefield NHS Foundation Trust's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Royal Brompton & Harefield NHS Foundation Trust focus on?
- Royal Brompton & Harefield NHS Foundation Trust's most-studied conditions on ClinicalTrials.gov are Cystic Fibrosis, Heart Failure, Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease, Lung Diseases.
- When are Royal Brompton & Harefield NHS Foundation Trust's next clinical trial readouts?
- Royal Brompton & Harefield NHS Foundation Trust has 2 upcoming primary-completion readouts tracked here; the soonest is “Corticosteroid Tapering in Sarcoidosis”, expected around 2027-06-28.